Per gram of cream: contains 20 mg Sertaconazole nitrate.
Sertaconazole is a new topical antimycotic endowed with a potent fungicide activity, with a broad activity spectrum where the pathogenic yeasts (Candida albicans, C. tropicalis, C. spp., Pityrosporum orbiculare), dermatophytes (Trichopyton, Epidermophyton and Microsporum) and other causing and accompanying agents in skin and mucous membranes infections like the gram-positive germs (Staphylococcus and Streptococcus) are included.
Topical treatment of surtace skin mycoses, such as dermatophytosis, Tinea pedis (athlete's foot), Tinea cruris (Hebra's eczema), Tinea corporis (herpes circinatus), Tinea barbae (beard mycosis) and Tinea manus, Candidiasis (Moniliasis) and Pityriasis versicolor (Pityrosporum orbiculare, Malassezia furtur formerly).
Apply the cream one or two times every day (preferably at night or in the morning and at night), mildly and uniformly on the lesion, trying, besides, to embrace 1 cm of sound skin (approximately) around the affected area.
The duration of the treatment to obtain the healing, varies from one patient to another, in function of the etiologic agent and location of the infection. In general, four weeks of treatment are recommended to ensure a complete clinical and microbiologic healing and the non appearance of relapses, though, in many cases, this clinical-microbiological healing appears earlier, between two and four weeks of treatment.
Considering the active substance concentration and the administration route, intoxication is impossible; however, in case of accidental ingestion, the appropriate symptomatic treatment should be applied.
ZALAIN should not be used for ophthalmological treatments.
After the topical application of big amounts, no plasma levels will be detected; in spite of this, its innocuousness in pregnant women has not been demonstrated; therefore the risk-benefit ratio should be evaluated before its use during pregnancy and in nursing mothers.
Its safety in local treatment is excellent; no toxic or photosensitizing effects have been observed. There have been isolated reports of slight local and transient erythematous reaction during the first treatment days; treatment discontinuance has not been required.
No interactions have been reported.
D01AC14 - sertaconazole ; Belongs to the class of imidazole and triazole derivatives. Used in the topical treatment of fungal infection.